glp-1 compounding crackdown news october 2025 The FDA announced plans to take action against non-FDA-approved receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the GLP-1 Shortage = Over -

Not your fingers, not the vial except through the stopper, not any surface

Compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across three commitment tiersyour dose may need to go up, but your price won't

In contrast, whether the unstable gut-derived GLP-1 directly acts on pancreatic -cells remains controversial [58]

Not usually, because general marketplace or retail listings often lack a third-party certificate of analysis and may not be true research-grade material

Non-alcoholic fatty liver disease (NAFLD) now affects up to a quarter of the global population, tightly linked to obesity, insulin resistance, and type 2 diabetes